Tuesday, January 19, 2016

Insights from Team NanoCliq...

I am Vibin with team NanoCliq. We are a second year Ti:GER team working in the immunotherapeutic space. My teammates are Rob Demont (PhD), Indra Datta (MBA), Bunny Sandefur (JD) and Nikki Leung (JD).  Our technology helps pharmaceutical companies reduce their preclinical testing time and shaves as much as 2-years off the drug discovery period. This translates to 2-years of additional patent protected revenue and for each blockbuster drugs that translates to at least $1 billion in additional revenue/year. We are a technology that serves the pharma world without getting caught in the muck of FDA approval. How cool is that!? Our market size in preclinical testing across all immunotherapeutics is estimated at $20 billion a year. Yes! We will turn into corporate leviathans, hell bent on world domination if things work out.

That’s us on the podium
Instead of boring y’all with further details of how cool the technology is, I thought I will give you a brief overview of what is ahead for us. We are on the cusp of getting this technology to market. One large pharmaceutical company initiated contact with us (name withheld for no reason other than to sound mysterious) and we are in discussions to get a first pilot going. This semester we worked on putting some structure to the business model and presenting it to the larger audience. We represented TI:GER at the Georgia Bio Innovation conference this November. For us, it was important to get the word out about NanoCliq and possibly find out at least two more partners to enter into a pilot project. 

For those who don’t know what GaBio Summit is, please see the links below: http://www.gabiosummit2015.com/

                                                                                              So what Next?
The full team in close up!
We have to iron out the details of our business model. The devil is unfortunately in the details. We have an idea of how we will make the revenue, what could the costs be and who are the partners required to get to market. That however will not be sufficient. We will have to structure the exact details, so that we can start negotiating for a deal with the pilot partners. This is going to be a lot of work, but we have an awesome team to get the things done. Before I wind up, a shout out to our awesome mentors MG. Finn, Richard DiMonda and Gary Busch.  Rich and MG went with us through every step of the process and we have a business model because of their help.  Also a big thank you to Bob McNally who sat with us and made GaBio Summit happen.

A final word on TI:GER:
It’s not possible to take something complex like an Immunotherapeutic technology to the market place without having a structure to frame the business. TI:GER is one of the most awesome programs to make this happen. TI:GER provides a solid dependable team, an extremely structured academic framework and super well connected and experienced network to make things happen. This program was the single most awesome experience in my entire educational experience till date. 

1 comment: